Intravenous Ibuprofen Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025
Intravenous (IV) Ibuprofen Market Size, Share and Industry Analysis By Indication (Pain and Inflammation, Fever, others), By Age Group (Pediatric and Adults), By Region (North America, Europe, Asia-Pacific, and Rest of the World), Competitive Market Share & Forecast, 2019 - 2025
The global intravenous ibuprofen market is expected to reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx% during the forecast period. Global Intravenous ibuprofen market report covers market size, market share and market forecast by product types, applications, regions, and key players, with historical data along with forecast from 2019 to 2025. The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Intravenous Ibuprofen Market Overview:
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve symptoms of pain, fever, and inflammation. Ibuprofen is also effective against conditions such as fever, menstrual cramps, headaches, toothaches, joint pain and backaches. This drug is available over the counter and can be purchased from supermarkets, general retail outlets or pharmacies. However, some of the restricted pack sizes and dosage forms are only available at a pharmacy outlet as a prescription medication. Ibuprofen is administered orally in the form of a tablet or capsule, topically through creams and parentally using injections. The intravenous ibuprofen market report mainly focuses on the market size and market share of the ibuprofen administered intravenously.
Ibuprofen, used in any form, has always been a primary drug of choice, in the reduction of fever in both adults and children. Also, intravenous NSAIDs such as intravenous ibuprofen are increasingly being used as a component of multimodal pain management in both, the inpatient as well as the outpatient settings. IV ibuprofen is also used to reduce post procedural / post-operative pain and as an alternative to opioids. Currently, the intravenous ibuprofen market is at a nascent stage, however advantages associated with the efficacy and effectiveness of this therapy compared to other drugs is expected to enhance its adoption during the forecast period.
Intravenous Ibuprofen Market Trends and Advancements:
Since a long time in the healthcare industry, ketorolac was the only intravenous NSAID available in the market. However, with introduction of ibuprofen as intravenous drug for the treatment of pain and fever in adults has gained a traction in the industry. In order to develop the intravenous ibuprofen market, number of clinical studies were conducted to compare the efficacy of IV ibuprofen over IV ketorolac. These studies also focused on evaluating and finalize on the intravenous dose and infusion levels compared to the oral route of administration. In May 2018 a study was published studying the efficacy of IV ibuprofen in patients with post-procedural pain and nausea associated with uterine fibroid embolization (UFE). This and many such studies proved its efficacy as an intravenous non-steroidal anti-inflammatory agent and now, the upcoming studies are focused towards assessment of analgesic and antipyretic effect of intravenous ibuprofen in a surgical setting. Moreover, combination products are also being developed and launched to improve the effect and surge the efficacy of the drug. These advancements are expected to provide significant growth opportunities in the intravenous ibuprofen market.
Intravenous Ibuprofen Market Drivers and Restraints:
Globally, the demand for intravenous ibuprofen has significantly increased because of the side effects of opioids, such as allergic reactions, sedation, respiratory depression, and gastrointestinal events. Thus, paradigm shift from opioids to non-opioid drugs is the primary factor driving the growth of intravenous ibuprofen market. Additionally, advantages associated with intravenous ibuprofen, such as rapid result and targeted drug delivery, have also resulted in the growth of intravenous ibuprofen market globally. Furthermore, increasing focus towards post-operative care, approval for application of IV ibuprofen in paediatric patients, growing incidences and prevalence of chronic diseases such as cardiac ailments, and cancer, along with other medical conditions such as dental ailments, orthopaedic conditions, trauma and many other conditions inducing pain and inflammation are also driving the adoption of intravenous ibuprofen. However, regulatory barriers in the process of product approval, and side effects associated with the drug are likely to hamper the growth of this market during the forecast period.
Intravenous Ibuprofen Market Segmentation and Geographic Outlook:
The intravenous ibuprofen market is segmented on the basis of indication, age group, and geography. On the basis of indication, the market is segmented into pain and inflammation, fever, others. The age group segment is divided into pediatric and adults. Geographic breakdown and deep analysis of each of the segments mentioned above is included for North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market by holding maximum market share of the global intravenous ibuprofen market. However, Asia-Pacific is expected to experience a fastest growth during the forecast period. Huge customer base, low manufacturing cost and growing number of product approvals are largely contributing to the growth of intravenous ibuprofen market in Asia-Pacific region. Moreover, increasing focus of key players towards expanding its business in this region also fuels the growth of this market.
Intravenous Ibuprofen Market Competitive Landscape:
As IV ibuprofen market is still at a nascent stage, there are number of companies aiming to enter this market and expand their wings on national as well as international level. Providing quality products and gaining competitive market share is the major focus of the players operating in this market. Numerous players are focusing on research and development and product launches as their primary growth strategy. For instance, in 2018 AFT Pharmaceuticals has developed Maxigesic intravenous formulation, a combination of paracetamol and ibuprofen, for infusion. The company signed a licensing agreement with Kyongbo Pharmaceutical Co., Ltd to commercialize its product in South Korea. Moreover, in January 2016 Piramal Critical Care and Cumberland Pharmaceuticals launched a co-promotion program to promote Cumberland’s Caldolor (ibuprofen) Injection and Vaprisol (conivaptan) Injection in the US market. Such activities enable the companies to enhance their geographic presence, maintain market position, and gain market share in this competitive industry.
A comprehensive and competitive analysis of market leaders is provided in this report. Some of the major players operating in the global intravenous ibuprofen market include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Laboratorios Valmorca, C.A., Sandor Medicaids Pvt Ltd., PT. Soho Industri Pharmasi, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd. and Germin MED.
What you get from the Intravenous Ibuprofen Market Research report:
· The study provides an in-depth analysis of the intravenous ibuprofen market with current and future trends to explain the imminent investment pockets in the market
· Current and future trends are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold in the market
· The report provides information regarding key drivers, restraints and opportunities with impact analysis
· Quantitative analysis of the current market and estimations through 2018-2025 are provided to showcase the financial caliber of the market
· Porters Five Forces model and SWOT analysis of the industry illustrates the potency of the buyers & suppliers participating in the market
· Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain
Choose License Type
Why Choose Us
24/5 Research support
Get your queries resolved from an industry expert.
Custom research service
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.